Wells Fargo & Company Ginkgo Bioworks Holdings, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 50,947 shares of DNA stock, worth $388,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,947
Previous 81,946
37.83%
Holding current value
$388,725
Previous $95,000
83.16%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding DNA
# of Institutions
243Shares Held
879MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$1.09 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$1.06 Billion0.0% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$533 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$321 Million0.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny31.4MShares$240 Million0.02% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $9.83B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...